Publications by authors named "Indranie Cooma"

Claim this Profile
C
Chemoprevention of colon carcinogenesis by oleanolic acid and its analog in male F344 rats and modulation of COX-2 and apoptosis in human colon HT-29 cancer cells.
Naveena B Janakiram, Cooma Indranie, Swamy V Malisetty, Patlolla Jagan, Vernon E Steele

Pharm Res· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-alpha in human colon cancer cells.
Naveena B Janakiram, Indranie Cooma, Altaf Mohammed, Vernon E Steele, Chinthalapally V Rao

Mol Cancer Ther· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low doses of beta-carotene and lutein inhibit AOM-induced rat colonic ACF formation but high doses augment ACF incidence.
Jayadev Raju, Malisetty V Swamy, Indranie Cooma, Jagan M R Patlolla, Brian Pittman

Int J Cancer· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatment.
Malisetty V Swamy, Indranie Cooma, Jagan M R Patlolla, Barbara Simi, Bandaru S Reddy

Mol Cancer Ther· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
Malisetty V Swamy, Indranie Cooma, Bandaru S Reddy, Chinthalapally V Rao

Int J Oncol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Chinthalapally V Rao, Cooma Indranie, Barbara Simi, Pamela T Manning, Jane R Connor

Cancer Res· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis